BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioNews
Biotechnology, Pharmaceutical and Life Science News
search help

Search Results

Documents 1-25 out of over 1000 found
  Current Search:  pharma: 9509, pharmaceut: 39133     

HTML
100%
Sciele Pharma, Inc. - Strategic Analysis Review - new market report published
Refer to a friend 2010-03-19 11:05:02 - Sciele Pharma, Inc.

- Strategic Analysis Review - a new market research report on companiesandmarkets.com Sciele Pharma, Inc.

- Strategic Analysis Review Summary The Sciele Pharma, Inc.

- Strategic...

PR inside:  Mar 19 2010 10:14AM
Matching: pharma pharmaceut
Find similar documents
HTML
100%
Purdue Pharma L.P. - Strategic Analysis Review - new market report published
Refer to a friend 2010-03-19 11:07:02 - Purdue Pharma L.P.

- Strategic Analysis Review - a new market research report on companiesandmarkets.com Purdue Pharma L.P.

- Strategic Analysis Review Summary The Purdue Pharma L.P.

- Strategic...

PR inside:  Mar 19 2010 10:14AM
Matching: pharma pharmaceut
Find similar documents
HTML
100%
Astellas Says Regulatory Waiting Period To Acquire OSI Pharma Expires - Update
(RTTNews) - Japanese pharmaceutial company Astellas Pharmaceuticals Inc.

(ALPMY.PK: News ) announced Friday that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, to acquire OSI Pharmaceuticals Inc.

...

RTTNews.com:  Mar 19 2010 10:44AM
Matching: pharma pharmaceut
Find similar documents
HTML
100%
A.P. Pharma sinks; sector indices sluggish
Biotechnology Pharmaceuticals AP Pharma Inc Nyse Arca Pharmaceutical Story Quotes Comments Screener AlertEmail Print By Val Brickates Kennedy APPADRG BTK BOSTON (MarketWatch) -- A.P.

Pharma /quotes/comstock/15*!appa/quotes/nls/appa ...

MarketWatch:  Mar 19 2010 2:24PM
Matching: pharma pharmaceut
Find similar documents
HTML
100%
A.P. Pharma Receives FDA Complete Response Letter for APF530
- REDWOOD CITY, Calif.--(BUSINESS WIRE)-- A.P.

Pharma, Inc.

(Nasdaq: APPA), a specialty pharmaceutical company, today announced that it received a Complete Response Letter from the U.S.

Food and Drug Administration (FDA or Agency) regarding...

Street Insider:  Mar 19 2010 11:49AM
Matching: pharma pharmaceut
Find similar documents
HTML
100%
A.P. Pharma Receives FDA Complete Response Letter for APF530
- REDWOOD CITY, Calif.--(BUSINESS WIRE)-- A.P.

Pharma, Inc.

(Nasdaq: APPA), a specialty pharmaceutical company, today announced that it received a Complete Response Letter from the U.S.

Food and Drug Administration (FDA or Agency) regarding...

Street Insider:  Mar 19 2010 11:48AM
Matching: pharma pharmaceut
Find similar documents
HTML
100%
A.P. Pharma Receives FDA Complete Response Letter for APF530
- REDWOOD CITY, Calif.--(BUSINESS WIRE)-- A.P.

Pharma, Inc.

(Nasdaq: APPA), a specialty pharmaceutical company, today announced that it received a Complete Response Letter from the U.S.

Food and Drug Administration (FDA or Agency) regarding...

Street Insider:  Mar 19 2010 11:48AM
Matching: pharma pharmaceut
Find similar documents
HTML
100%
A.P. Pharma Receives FDA Complete Response Letter for APF530
- REDWOOD CITY, Calif.--(BUSINESS WIRE)-- A.P.

Pharma, Inc.

(Nasdaq: APPA), a specialty pharmaceutical company, today announced that it received a Complete Response Letter from the U.S.

Food and Drug Administration (FDA or Agency) regarding...

Street Insider:  Mar 19 2010 11:43AM
Matching: pharma pharmaceut
Find similar documents
HTML
100%
The Specialty Pharmaceutical Market Outlook: Key players, opportunities and future trends - new market report published
Refer to a friend 2010-03-19 19:09:03 - The Specialty Pharmaceutical Market Outlook: Key players, opportunities and future trends - a new market research report on companiesandmarkets.com The Specialty Pharmaceuticals Market Outlook reveals market...
PR inside:  Mar 19 2010 6:55PM
Matching: pharma pharmaceut
Find similar documents
HTML
100%
Axcan Pharma Inc. - Strategic Analysis Review - new market report published
Axcan Pharma Inc.

- Strategic Analysis Review Summary The Axcan Pharma Inc.

- Strategic Analysis Review is an in-depth business and strategic analysis of Axcan Pharma Inc..

The report provides a comprehensive insight into the company,...

PR inside:  Mar 19 2010 10:26AM
Matching: pharma pharmaceut
Find similar documents
HTML
100%
Purdue Pharma L.P. - Strategic Analysis Review
SummaryThe '' is an in-depth business and strategic analysis of 'Purdue Pharma L.P.'.

The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors.

The hallmark of...

companiesandmarkets.com:  Mar 19 2010 9:13AM
Matching: pharma pharmaceut
Find similar documents
HTML
100%
A.P. Pharma Receives FDA Complete Response Letter for APF530
Pharma, Inc.

(Nasdaq:APPA), a specialty pharmaceutical company, today announced that it received a Complete Response Letter from the U.S.

Food and Drug Administration (FDA or Agency) regarding its New Drug Application (NDA) for APF530 in the...

Genetic Engineering News:  Mar 19 2010 11:48AM
Matching: pharma pharmaceut
Find similar documents
HTML
100%
A.P. Pharma Receives FDA Complete Response Letter for APF530
REDWOOD CITY, Calif.--(BUSINESS WIRE)--A.P.

Pharma, Inc.

(Nasdaq: APPA), a specialty pharmaceutical company, today announced that it received a Complete Response Letter from the U.S.

Food and Drug Administration (FDA or Agency) regarding its...

Yahoo! Canada:  Mar 19 2010 11:46AM
Matching: pharma pharmaceut
Find similar documents
HTML
100%
A.P. Pharma Receives FDA Complete Response Letter for APF530
Companies mentioned in this article: A.P.

Pharma, Inc.

REDWOOD CITY, Calif.

-- (BUSINESS WIRE) -- A.P.

Pharma, Inc.

(Nasdaq:APPA), a specialty pharmaceutical company, today announced that it received a Complete Response Letter from...

Freshnews.com:  Mar 19 2010 11:46AM
Matching: pharma pharmaceut
Find similar documents
HTML
100%
A.P. Pharma Receives FDA Complete Response Letter for APF530
REDWOOD CITY, Calif.(BUSINESS WIRE) A.P.

Pharma, Inc.

(Nasdaq:APPA), a specialty pharmaceutical company, today announced that it received a Complete Response Letter from the U.S.

Food and Drug Administration (FDA or Agency) regarding its New...

Your Story:  Mar 19 2010 11:34AM
Matching: pharma pharmaceut
Find similar documents
HTML
100%
A.P. Pharma Receives FDA Complete Response Letter for APF530
(BUSINESS WIRE) -- A.P.

Pharma, Inc.

(Nasdaq:APPA), a specialty pharmaceutical company, today announced that it received a Complete Response Letter from the U.S.

Food and Drug Administration (FDA or Agency) regarding its New Drug Application ...

Pharma Live:  Mar 19 2010 4:45PM
Matching: pharma pharmaceut
Find similar documents
HTML
100%
A.P. Pharma Receives FDA Complete Response Letter for APF530
(BUSINESS WIRE) -- A.P.

Pharma, Inc.

(Nasdaq:APPA), a specialty pharmaceutical company, today announced that it received a Complete Response Letter from the U.S.

Food and Drug Administration (FDA or Agency) regarding its New Drug Application ...

Therapeutics Daily:  Mar 19 2010 1:53PM
Matching: pharma pharmaceut
Find similar documents
HTML
100%
A.P. Pharma Receives FDA Complete Response Letter for APF530
BusinessWire - A.P.

Pharma, Inc.

(Nasdaq:APPA), a specialty pharmaceutical company, today announced that it received a Complete Response Letter from the U.S.

Food and Drug Administration (FDA or Agency) regarding its New Drug Application (NDA)...

Forbes.com:  Mar 19 2010 11:52AM
Matching: pharma pharmaceut
Find similar documents
HTML
100%
Sun Pharma Announces USFDA Approval for Generic Prometh Syrup
Source : Sun Pharmaceuticals Industries Ltd Sun Pharma Announces USFDA Approval for Generic Prometh Syrup Sun Pharmaceutical Industries Ltd.

(Reuters: SUN.BO, Bloomberg: SUNP IN, NSE:SUNPHARMA, BSE: 524715) announced that the USFDA has...

Businessworld India:  Mar 19 2010 7:17AM
Matching: pharma pharmaceut
Find similar documents
HTML
100%
The Specialty Pharmaceutical Market Outlook: Key players, opportunities and future trends - new market report
The Specialty Pharmaceuticals Market Outlook reveals market dynamics, leading players and key therapy areas of opportunity for specialty pharma companies.

Market drivers include increasing reimbursement from national health bodies and governments,...

PR inside:  Mar 19 2010 6:23PM
Matching: pharma pharmaceut
Find similar documents
HTML
100%
Astellas Announces Changes to Director Nominees for Election to OSI Pharmaceuticals' Board of Directors
See more news releases in: Health Care & Hospitals, Medical Pharmaceuticals, Pharmaceuticals, Personnel Announcements TOKYO, March 19 /PRNewswire/ -- Astellas Pharma Inc.

(TSE: 4503) today notified OSI Pharmaceuticals Inc.

...

PR Newswire:  Mar 19 2010 8:17PM
Matching: pharma pharmaceut
Find similar documents
HTML
100%
FDA Denies Approval For A. P. Pharma's Nausea Treatment
The Food and Drug Administration issued a complete response letter to A.

Pharma Inc.

(Nasdaq: APPA) denying approval for the company's chemotherapy induced nausea treatment APF530 sending the stock price plummeting 91 cents to $1.15.

The Food and...

About:  Mar 19 2010 5:33PM
Matching: pharma pharmaceut
Find similar documents
HTML
100%
A.P. Pharma Receives FDA Complete Response Letter for APF530
REDWOOD CITY, Calif.

Pharma, Inc.

(Nasdaq:APPA), a specialty pharmaceutical company, today announced that it received a Complete Response Letter from the U.S.

Food and Drug Administration (FDA or Agency) regarding its New Drug Application (NDA...

Centre Daily Times:  Mar 19 2010 12:11PM
Matching: pharma pharmaceut
Find similar documents
HTML
100%
A.P. Pharma Receives FDA Complete Response Letter for APF530
- Company to host conference call at 9:00 a.m.

ET on Friday, March 19, 2010 - REDWOOD CITY, Calif.--(BUSINESS WIRE)--A.P.

Pharma, Inc.

(Nasdaq:APPA - News), a specialty pharmaceutical company, today announced that it received a Complete...

Yahoo! Canada:  Mar 19 2010 11:54AM
Matching: pharma pharmaceut
Find similar documents
HTML
100%
A.P. Pharma Receives FDA Complete Response Letter for APF530
REDWOOD CITY, Calif.--(EON: Enhanced Online News)--A.P.

Pharma, Inc.

(Nasdaq:APPA), a specialty pharmaceutical company, today announced that it received a Complete Response Letter from the U.S.

Food and Drug Administration (FDA or Agency)...

EON:  Mar 19 2010 11:46AM
Matching: pharma pharmaceut
Find similar documents


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.